Nitrate tolerance is specific for nitric acid esters and its recovery requires an intact protein synthesis

被引:17
作者
Hinz, B [1 ]
Schröder, H [1 ]
机构
[1] Univ Halle Wittenberg, Sch Pharm, Dept Pharmacol & Toxicol, D-06099 Halle, Germany
关键词
D O I
10.1006/bbrc.1998.9630
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Using cultured LLC-PK1 cells the present study investigates mechanisms leading to nitrate tolerance and its reversal A 5-h pretreatment with glyceryl trinitrate (GTN, 0.01-100 mu M) resulted in desensitization of the intracellular cyclic GMP response to a subsequent 10-min challenge with GTN (1 mu M). The spontaneous donor of nitric oxide (NO) spermine NONOate, which releases NO independently of enzymatic catalysis, did not induce tolerance to its own cyclic GMP stimulatory effect and remained fully effective in GTN-tolerant cells. Tolerant cells regained sensitivity to GTN after a 30-h incubation in media. Recovery of the cyclic GMP response was blocked in the presence of cycloheximide (10 mu M) suggesting that de novo protein synthesis is necessary for tolerance reversal. Our results demonstrate that nitrate tolerance is specific for nitric acid esters and possibly due to down-regulation of enzymes involved in bioactivation of, and NO generation from, organic nitrates. (C) 1998 Academic Press.
引用
收藏
页码:232 / 235
页数:4
相关论文
共 30 条
[1]
Tolerance: An historical overview [J].
Abrams, J ;
Elkayam, U ;
Thadani, U ;
Fung, HL .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (1A) :3A-14A
[2]
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[3]
BENNETT BM, 1989, J PHARMACOL EXP THER, V250, P316
[4]
INHIBITION OF NITROVASODILATOR-INDUCED AND ACETYLCHOLINE-INDUCED RELAXATION AND CYCLIC-GMP ACCUMULATION BY THE CYTOCHROME-P-450 SUBSTRATE, 7-ETHOXYRESORUFIN [J].
BENNETT, BM ;
MCDONALD, BJ ;
NIGAM, R ;
LONG, PG ;
SIMON, WC .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (09) :1297-1303
[5]
BOGAERT MG, 1968, ARCH INT PHARMACOD T, V171, P221
[6]
Crandall LA, 1931, J PHARMACOL EXP THER, V41, P103
[7]
Dikalov S, 1998, J PHARMACOL EXP THER, V286, P938
[8]
Feelisch M., 1996, M ETHODS NITRIC OXID, P71
[9]
FORSTER S, 1991, J CARDIOVASC PHARM, V17, P867
[10]
THE NITROVASODILATORS - NEW IDEAS ABOUT OLD DRUGS [J].
HARRISON, DG ;
BATES, JN .
CIRCULATION, 1993, 87 (05) :1461-1467